tiprankstipranks
Immunogen (IMGN)
NASDAQ:IMGN
Holding IMGN?
Track your performance easily

ImmunoGen (IMGN) Financial Statements

1,265 Followers

ImmunoGen Financial Overview

ImmunoGen's market cap is currently ―. The company's EPS TTM is $-0.299; its P/E ratio is -104.24; ImmunoGen is scheduled to report earnings on May 3, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 113.42M$ 77.37M$ 800.00K$ 1.10M$ 15.38M
Gross Profit$ 113.42M$ 83.15M$ 800.00K$ 1.10M-
EBIT$ 32.08M$ -3.37M$ -41.01M$ -63.14M$ -76.89M
EBITDA-$ -3.95M$ -41.55M-$ -76.46M
Net Income Common Stockholders$ 38.65M$ -4.25M$ -41.01M$ -59.01M$ -77.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 605.50M$ 572.00M$ 201.20M$ 275.10M$ 309.51M
Total Assets$ 822.10M$ 714.33M$ 288.35M$ 348.87M$ 358.80M
Total Debt$ 84.33M$ 85.21M$ 14.26M$ 15.24M$ 16.20M
Net Debt$ -521.17M$ -486.79M$ -186.94M$ -259.86M$ -293.31M
Total Liabilities$ 260.50M$ 223.49M$ 166.43M$ 343.01M$ 180.79M
Stockholders Equity$ 561.60M$ 490.84M$ 121.92M$ 149.90M$ 178.01M
Cash Flow-
Free Cash Flow-$ -68.09M$ -73.93M$ -61.00M$ -64.81M
Operating Cash Flow$ 2.77M$ -68.01M$ -73.72M$ -60.75M$ -64.21M
Investing Cash Flow$ -1.35M$ 1.16M$ -209.00K$ 330.00K$ -602.00K
Financing Cash Flow$ 32.13M$ 437.56M$ 39.00K$ 26.07M$ 449.00K
Currency in USD

ImmunoGen Earnings and Revenue History

ImmunoGen Debt to Assets

ImmunoGen Cash Flow

ImmunoGen Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis